维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="CSAJKA C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospec- tive Study显示文摘	Panchaud A Csajka C Merlob P	2012	J Clin Pharmacol2012，52，12：	1
2	Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients显示文摘	Ostermann S Csajka C Buclin T	2004	Clin Cancer Res2004，10，：	1
3	Phamacokinetic phamacodynamic profille of angiotensin Ⅱ receptor antagonists显示文摘	Buclin T Brunner HRr	1997	Clin Phamacokinetics1997，32，：	1
4	Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients显示文摘	Ostermann S Csajka C Buclin T	2004	Clin Cancer Res2004，10，11：	1
5	Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety : population pharmacokinetics- based analysis of adult patients with invasive fungal infections显示文摘	PASCUAL A CSAJKA C BUCLIN T	2012	Clin Infect Dis2012，55，3：	1
6	Pharrnacokinetic-pbarmacodynamic modelling: history and perspectives 显示文摘	CSAJKA C VEROTTA D	2006	J Pharmacokinet Pharmacodyn2006，33，3：	1
7	Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection显示文摘	Csajka C	2003	Clin Pharmacol Ther2003，73，1：	1
8	Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients显示文摘	Ostermann S Csajka C Buclin T	2004	Clin Cancer Res2004，10，11：	1
9	Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies显示文摘	Lamoth F Buclin T Csajka C	2009	Antimicrob Agents Chemother2009，53，2：	1
10	Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein 显示文摘	Widmer N Decosterd LA Csajka C	2006	Br J Clin Pharmacol2006，62，：	1
11	Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients显示文摘	Ostermann S Csajka C Buclin J	2004	Clin Cancer Res2004，10，11：	1
12	Plasma and Cerebrospinal Fluid Population Pharmaeokinetics of Temozolomidein Malignant Glioma Patients显示文摘	Ostermann S Csajka C Buclin T et a1	2004	Clin Cancer Res2004，10，11：	1
13	Pharmakenatic-pharmacodynamic profile of angiotensin Ⅱ receptor antagonists显示文摘	Csajka C Buclin T Bruner HR	1997	Clin Pharmacokinet1997，32，：	1
14	Reassessment of reeommended imipenem doses in febrile nentropenic pa- tients with hematologieal malignaneies 显示文摘	Lamoth F Buelin T Csajka C	2009	Antimicrob Agents Chemother2009，53，：	1
15	Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients 显示文摘	OSTERMANN S CSAJKA C BUCLIN T	2004	Clin Cancer Res2004，10，11：	1
16	Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients 显示文摘	Ostermann S Csajka C Buclin T	2004	Clin Cancer Res2004，10，11：	1
17	Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients 显示文摘	Ostermann S Csajka C Buclin T	2004	Clin Cancer Res2004，10，11：	1
18	Population pharmacokinetics of imatinib and the role of α-acid glycoprotein显示文摘	Widmer N Decosterd LA Csajka C	2006	Br J Clin Pharmacol2006，62，：	1
19	Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections显示文摘	Pascual A Csajka C Buclin T	2012	Clin Infect Dis2012，55，3：	1
20	Population pharmacokinetis of fluconazole given for secondary prevention of orpharyngral cardidiasis in HIV-positive patients 显示文摘	Csajka C Decostered LA Buclin T	2001	Eun J Clin Pharmacol2001，57，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示